HEREDITARY NEPHROGENIC DIABETES-INSIPIDUS RENALIS IN THE DOG .2. THERAPY

被引:0
|
作者
GRUNBAUM, EG
HERZOG, A
RASCHER, W
FAHRENHOLZ, F
LUZIUS, H
JANS, D
MORITZ, A
机构
[1] UNIV GIESSEN,INST TIERZUCHT & HAUSTIERGENET,D-35392 GIESSEN,GERMANY
[2] UNIV ESSEN GESAMTHSCH KLINIKUM,ZENTRUM KINDER & JUGENDMED,D-45147 ESSEN,GERMANY
[3] MAX PLANCK INST BIOPHYS,D-60596 FRANKFURT,GERMANY
来源
KLEINTIERPRAXIS | 1995年 / 40卷 / 07期
关键词
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
In this study canine hereditary nephrogenic diabetes insipidus in a family of huskies is reported (part 1 diagnosis). In this second part, the following methods of treatment were evaluated: treatment with a low-sodium, low-protein diet in addition to a low-sodium, low-protein diet hydrochlorothiazide (HCT) treatment, also combined with other drugs HCT and indomethacin treatment arginine-vasopressin and vasopressin agonists at high dosages long-term treatment with the vasopressin agonists dDAVP, dVSAVP, and SAVP The daily uptake of drinking water in the treated huskies was easily reduced by a mean value of 30 % without any risks by feeding a low-sodium, low-protein diet. A maximum reduction of the daily water uptake by 24,4 % was achieved with the usual HCT (Esidrix(R)) treatment, indomethacin treatment as well as the combination of both methods. A reduction of the water uptake by 60,2 % was managed by the combination of a low-sodium, low-protein diet, aminophylline, fludrocortisone, and potassium applications with HGT (Esidrix(R)). The use of the AVP agonist dDAVP (Minirin(R)), dVSAVP, and SAVP combined with a low-sodium, low-protein diet allowed a reduction of the daily water uptake by up to 70,38 %, depending on the dosage and the form of application.
引用
收藏
页码:501 / &
相关论文
共 50 条
  • [21] VASOPRESSIN SECRETION IN NEPHROGENIC DIABETES-INSIPIDUS
    LAROCHELLE, FT
    STERN, P
    CLINICAL RESEARCH, 1982, 30 (02): : A455 - A455
  • [22] NEPHROGENIC DIABETES-INSIPIDUS AND OBSTRUCTIVE UROPATHY
    AARONSON, IA
    WIGGELINKHUIZEN, J
    BRITISH JOURNAL OF UROLOGY, 1985, 57 (01): : 110 - 111
  • [23] NEPHROGENIC DIABETES-INSIPIDUS AND OBSTRUCTIVE UROPATHY
    WIGGELINKHUIZEN, J
    RETIEF, PJM
    WOLFF, B
    FISHER, RM
    CREMIN, BJ
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1973, 126 (03): : 398 - 401
  • [24] GROWTH FAILURE - NEPHROGENIC DIABETES-INSIPIDUS
    LINSHAW, MA
    STAPLETON, FB
    KNAPP, J
    JOURNAL OF THE KANSAS MEDICAL SOCIETY, 1977, 78 (07): : 345 - 347
  • [25] A FAMILY CASE OF NEPHROGENIC DIABETES-INSIPIDUS
    OKAYASU, T
    SHIGIHARA, K
    KOBAYASHI, N
    ISHIKAWA, A
    FUKUSHIMA, N
    TAKASE, A
    HATTORI, S
    NAKAJIMA, T
    SHISHIDO, T
    AGATSUMA, Y
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 162 (02): : 137 - 145
  • [26] NEPHROGENIC DIABETES-INSIPIDUS IN 5 SIBLINGS
    HOCHBERG, Z
    HAREFUAH, 1977, 92 (03) : 118 - 120
  • [27] TRANSIENT, RECURRENT NEPHROGENIC DIABETES-INSIPIDUS
    GOODMAN, H
    SACHS, BP
    PHILLIPPE, M
    MOORE, T
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 149 (08) : 910 - 912
  • [28] MOLECULAR CHARACTERIZATION OF NEPHROGENIC DIABETES-INSIPIDUS
    KNOERS, NVAM
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1994, 5 (10): : 422 - 428
  • [29] NEPHROGENIC DIABETES-INSIPIDUS - CAUSES REVEALED
    HOLTZMAN, EJ
    AUSIELLO, DA
    HOSPITAL PRACTICE, 1994, 29 (03): : 89 - &
  • [30] CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS IN AN ADULT
    ISHII, H
    MIZUNO, K
    NIIMURA, S
    HAGA, H
    TAKAHASHI, M
    WATANABE, Y
    TANAKA, K
    OGATA, M
    TANAKA, N
    FUKUCHI, S
    INTERNAL MEDICINE, 1993, 32 (02) : 133 - 138